RNS Number : 6470F
Duke Royalty Limited
18 November 2020
18 November 2020
Duke Royalty Limited
("Duke Royalty", "Duke" or the "Company")
Notice of Interim Results
Duke Royalty Limited (AIM: DUKE), a provider of capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, will announce its Interim Results for the six months ended 30 September 2020 ("H1 2020") on 9 December 2020.
***ENDS***
For further information, please visit
www.dukeroyalty.com
, or contact:
|
Duke Royalty Limited
|
Neil Johnson / Charlie Cannon Brookes / Hugo Evans
|
+44 (0) 1481 741 240
|
|
Cenkos Securities plc
(Nominated Adviser and Joint Broker)
|
Stephen Keys / Callum Davidson / Julian Morse / Michael Johnson
|
+44 (0) 207 397 8900
|
|
Canaccord Genuity
(Joint Broker)
|
Adam James / Georgina McCooke
|
+44 (0) 207 523 8000
|
|
Newgate Communications (PR)
|
Elisabeth Cowell/ Ian Silvera/ Megan Kovach
|
+
+44 (0) 20 3757 6880
dukeroyalty@newgatecomms.com
|
About Duke Royalty
Duke Royalty Limited provides capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long-term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END
NORKDLFFBFLXFBL
|
